| 

Product Pipeline

Our recent investments in research and development have led to a number of projects at advanced stages of clinical development. Examples of these advanced developments include the patent-protected new formulation of tolperisone, a centrally acting muscle relaxant, and PVP hypericine, a photoactive substance for the diagnosis and treatment of bladder carcinomas. Development projects inevitably entail the risk of unforeseen complications. Our strategy of spreading projects across various potentially lucrative therapeutic areas and different stages of development helps us to minimise the associated risks.

  

Go to top
Print